Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women
NCT ID: NCT03918668
Last Updated: 2021-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2018-07-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Some cell mutations, especially in the BRCA1, BRCA2 and p53 genes, are associated with a very high risk of this type of cancer. Some authors have calculated the contribution of various modifiable risk factors to the global burden of breast cancer, and they concluded that 21% of all breast cancer deaths are attributable to alcohol consumption, overweight and obesity, and lack of physical activity. Nowadays, there aren't specific studies in the Community of Madrid designed to know the risk factors related to breast cancer.
For this reason, it is proposed to carry out an observational study that collects detailed information about dietary habits, genetic factors and life quality of a group of women with recent diagnosis in pre or post-surgical phase.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method Approach
NCT00393406
Towards Early Detection of Breast Cancer in High Risk Population
NCT05268913
Healthy Lifestyles and Quality of Life in Women With Breast Cancer
NCT04379908
Breast Cancer and Its Relationship With the Microbiota
NCT03885648
Breast Cancer and Quality of Life
NCT01661816
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Patient's breast pathology characteristics.
3. Study of concomitant pathologies.
4. Dietary study: "Frequency of Food Consumption" questionnaire referring to the last year eating habits before having been breast cancer diagnosed.
5. Physical activity study in the year prior to the diagnosis of breast cancer.
6. Anthropometric study: weight, size, waist circumference and body composition (% Fat mass,% Lean mass,% Body water).
7. Study of other risk factors of breast cancer: age, family history, reproductive history, medications consumed...
8. Biochemical study: biochemical variables of the last blood analysis performed on the volunteer in the hospital center.
9. Saliva collection to proceed with the genetic analysis.
10. Collection of stool sample to carry out the microbiota study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Women with recent diagnosis of breast cancer
To evaluate dietary habits of a group of women with pre and post-surgical breast cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly diagnosed patients with a breast tumor (Phase I, II or III). Being in one of the following cases:
1. Patient who has not yet received any treatment and the committee has decided that as a first treatment will receive chemo or radiotherapy.
2. Patient who has just undergone surgery and is waiting to start adjuvant treatment with chemo or radiotherapy.
* Sign the informed consent.
Exclusion Criteria
* Associated Eating Disorders.
* Patients with dementia, mental illness or decreased cognitive function.
* Pregnant or lactating women.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Investigación Hospital Universitario La Paz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carmen Gómez Candela, Msc
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario La Paz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Health Research IdiPAZ
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI-2842
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.